Rossari Biotech Limited
NSE: ROSSARISpecialty Chemicals
Share price
₹409.80
-3.10% close of 8 Oct 2026
Business score
How strong the business is, in one number. The parts behind it are in Pro.
73
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹2,254 Cr
P/E ratio
15.0
P/B ratio
1.7
ROCE
13.3%
ROE
10.8%
Dividend yield
0.1%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 19.5% over the past year, and 25.9% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 12.0% to 11.7% over the last four years.
Whether it grew faster than its sector
It grew 25.9% a year against a sector median of 10.2% — 15.7 percentage points faster.
Room to re-rate, or risk of de-rating
At 15.0× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 56.2×, across 5 companies. It is against its own five-year median of 33.7×, the 0th percentile of its own range.
Whether growth justifies the valuation
Priced at 1.9 times its growth rate, on earnings growth of 8%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Rossari Biotech Limited — this one | 8%/yr | 15.0× | ₹1.9 |
| Pidilite Industries | 25%/yr | 56.2× | ₹2.2 |
| Gujarat Fluorochemicals Limited | -24%/yr | 79.0× | — |
| Navin Fluorine International Limited | 21%/yr | 53.0× | ₹2.5 |
| Aether Industries Limited | 20%/yr | 96.7× | ₹4.8 |
| Deepak Nitrite Limited | -13%/yr | 27.0× | — |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Specialty Chemicals), it ranks 32 of 73 on returns, 5 of 72 on growth, 39 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
A narrow advantage: it earns 13.3% on capital, ahead of 56% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
No — Over the last five years it made ₹426 crore of cash from the business but spent ₹592 crore on plant and equipment, ₹166 crore more than it made; the gap was from lenders and shareholders. And the profit is real: of every 100 rupees it reported over 8 years, about 74 arrived as cash. Its cash comes back faster than it used to: it went from being waiting 62 days for its cash to waiting 49 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
8 of 9 checks clear · 89%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Announced 18 Jul 2026 · Consolidated · Unaudited
Revenue
₹697 Cr
Revenue vs last year
+28.2%
Revenue vs last quarter
+1.8%
Net profit
₹35 Cr
Profit vs last year
+3.2%
Profit vs last quarter
-23.7%
Net margin
5.0%
EPS
₹6.34
Earnings call transcript · 20 Jul 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹2,254 Cr
- Prev close
- ₹409.80
- 52w High
- ₹690
- 52w Low
- ₹375
- Enterprise value
- ₹2,563 Cr
- Beta
- 1.0
- Price CAGR 1y
- -37.0%
- Price CAGR 3y
- -20.0%
- Price CAGR 5y
- -22.0%
- Price CAGR 10y
- —
Ratios
- Return on assets
- 6.6%
- PEG ratio
- 1.9
- P/E ratio
- 15.0
- P/B ratio
- 1.7
- EV / EBITDA
- 8.6
- Industry P/E
- 32.7
- ROCE
- 13.3%
- ROCE 5y average
- 17.8%
- ROE
- 10.8%
- Debt / Equity
- 0.3
- Interest coverage
- 8.0
- Dividend yield
- 0.1%
- ROE 3y average
- 12.0%
- ROE last year
- 11.0%
Annual P&L
- Annual revenue
- ₹2,396 Cr
- Annual profit
- ₹149 Cr
- Operating margin
- 12.0%
- Net profit margin
- 6.2%
- EBITDA margin
- 11.9%
- Sales growth 3y
- 13.1%
- Sales growth 5y
- 27.6%
- Profit growth 3y
- 8.0%
- Profit growth 5y
- 11.0%
- EPS
- ₹26.9
- Sales growth TTM
- 19.0%
- Profit growth TTM
- 12.0%
- Dividend payout
- 2.0%
Quarter P&L
- Sales latest quarter
- ₹697 Cr
- Profit latest quarter
- ₹35 Cr
- YoY quarterly sales growth
- 28.2%
- YoY quarterly profit growth
- 2.9%
- OPM latest quarter
- 11.6%
Balance Sheet
- Book Value
- ₹242
- Face Value
- ₹2.0
- Total debt
- ₹436 Cr
- Total cash
- ₹92 Cr
- Borrowings
- ₹436 Cr
- Reserves / Equity
- 120.2
Cash Flow
- Operating cash flow
- ₹65 Cr
- Free cash flow
- -₹175 Cr
- FCF yield
- -9.0%
- Net cash flow
- ₹31 Cr
Shareholding
- Promoter holding
- 68.1%
- FII holding
- 2.0%
- DII holding
- 14.6%
- Public holding
- 15.2%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | 1,475.30 | 56.7 | 1,50,265 | 0.77 | 883.5 | 28.2 | 4,551.6 | 21.3 | 31.0 |
| Gujarat Fluoroch | 4,469.75 | 79.5 | 49,100 | 0.07 | 219.0 | 21.4 | 1,588.0 | 24.0 | 9.6 |
| Navin Fluo.Intl. | 8,494.75 | 54.8 | 43,590 | 0.18 | 243.3 | 107.7 | 1,045.1 | 44.1 | 21.0 |
| Aether Industri. | 1,763.90 | 97.6 | 23,412 | 0.00 | 62.8 | 28.0 | 326.6 | 27.3 | 11.9 |
| Deepak Nitrite | 1,591.75 | 27.4 | 21,710 | 0.46 | 345.0 | 207.5 | 2,577.6 | 36.4 | 11.4 |
| Atul | 5,979.20 | 22.1 | 17,604 | 0.50 | 253.9 | 92.0 | 1,848.0 | 25.0 | 14.9 |
| Aarti Industries | 483.30 | 33.5 | 17,531 | 0.20 | 155.0 | 256.5 | 2,387.0 | 42.5 | 6.9 |
| Rossari Biotech | 412.65 | 15.2 | 2,286 | 0.12 | 35.1 | 4.5 | 697.2 | 28.2 | 13.3 |
| Median | 356.77 | 28.1 | 1,043 | 0.23 | 13.5 | 51.6 | 174.4 | 26.0 | 13.7 |
Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 411 | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 | 685 | 697 |
| Expenses | 353 | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 | 617 |
| Material Cost | 370 | 334 | 407 | 418 | 444 | 515 | |||||||
| Change in Inventories | -2.01 | 7.99 | -36 | -28 | 27 | -39 | |||||||
| Purchases of Stock-in-Trade | 34 | 29 | 29 | 11 | 24 | 15 | |||||||
| Employee Cost | 35 | 37 | 38 | 40 | 39 | 44 | |||||||
| Other Expenses | 73 | 67 | 76 | 72 | 73 | 82 | |||||||
| Operating Profit | 58 | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 | 77 | 81 |
| OPM % | 14 | 13 | 14 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 11 | 12 |
| Other Income | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 | 4 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Interest | 6 | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 |
| Depreciation | 14 | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 | 26 |
| Profit before tax | 39 | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 | 48 |
| Tax % | 26 | 26 | 28 | 25 | 26 | 27 | 25 | 28 | 27 | 26 | 23 | 28 | 26 |
| Net Profit | 29 | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 | 46 | 35 |
| EPS in Rs | 5.30 | 5.97 | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 | 6.34 |
| Diluted EPS in Rs | 6.21 | 6.06 | 6.65 | 5.91 | 8.29 | 6.33 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 516 | 600 | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 | 2,550 |
| Expenses | 438 | 495 | 586 | 1,299 | 1,433 | 1,581 | 1,815 | 2,110 | 2,251 |
| Material Cost | 1,300 | 1,604 | |||||||
| Change in Inventories | -31 | -28 | |||||||
| Purchases of Stock-in-Trade | 165 | 93 | |||||||
| Employee Cost | 132 | 155 | |||||||
| Other Expenses | 250 | 287 | |||||||
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 286 | 299 |
| OPM % | 15 | 17 | 17 | 12 | 13 | 14 | 13 | 12 | 12 |
| Other Income | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 24 | 26 |
| Exceptional items (within Other Income) | 0 | 0 | |||||||
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 | 34 |
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 | 87 |
| Profit before tax | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 | 204 |
| Tax % | 28 | 26 | 25 | 28 | 26 | 26 | 26 | 26 | |
| Net Profit | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 149 | 151 |
| EPS in Rs | 104 | 13 | 15 | 18 | 19 | 24 | 25 | 27 | 27 |
| Diluted EPS in Rs | 25 | 27 | |||||||
| Dividend Payout % | 0 | 4 | 3 | 3 | 3 | 2 | 2 | 2 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 28%
- 3 years
- 13%
- TTM
- 19%
Compounded profit growth
- 10 years
- —
- 5 years
- 11%
- 3 years
- 8%
- TTM
- 12%
Stock price CAGR
- 10 years
- —
- 5 years
- -22%
- 3 years
- -20%
- 1 year
- -37%
Return on equity
- 10 years
- —
- 5 years
- 13%
- 3 years
- 12%
- Last year
- 11%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,322 |
| Borrowings | 8 | 67 | 0 | 8 | 74 | 119 | 218 | 436 |
| Other Liabilities | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 505 |
| Total Liabilities | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,274 |
| Fixed Assets | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 784 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 173 |
| Investments | 0 | 18 | 0 | 36 | 51 | 63 | 84 | 62 |
| Other Assets | 173 | 338 | 379 | 611 | 712 | 880 | 1,063 | 1,254 |
| Total Assets | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,896 | 2,274 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
| Cash from Investing Activity | -37 | -190 | -37 | -299 | -181 | -103 | -183 | -220 |
| Cash from Financing Activity | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 | 31 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 | -175 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 57 | 74 | 75 | 78 | 85 | 83 | 85 |
| Inventory Days | 59 | 57 | 75 | 63 | 59 | 80 | 90 | 88 |
| Days Payable | 114 | 95 | 104 | 61 | 56 | 62 | 73 | 71 |
| Cash Conversion Cycle | 6 | 19 | 46 | 76 | 80 | 103 | 101 | 103 |
| Working Capital Days | 23 | 22 | 60 | 62 | 49 | 70 | 69 | 49 |
| ROCE % | 38 | 29 | 24 | 18 | 18 | 16 | 13 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
exports as % of revenue
26.00
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
total loans / revolving facilities outstanding at period end, the base of loan_default_cr
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
309inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
FY revenue / permanent employees + workers, same basis (calc)
2,99,49,846inr
2026-03-31
News
News and filings about Rossari Biotech Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Acetic acid
- Acrylic acid
- Ethylene oxide
- Silicone oil
- Surfactants
Depends on the price of
- Crude Oil Brent
Sells to
- Arvind Limited · Textile specialty chemicals
- BSH Household Appliances (Bosch) · B2B laundry/dishwasher detergent formulations
- Bhaskar Denim · Textile specialty chemicals
- CICO Technologies · Performance/construction specialty chemicals
- Hindustan Unilever · Ingredients/formulations for soaps, detergents, home & personal care
- Hitech Hatch Fresh Pvt. Ltd. · Vitamin premix, enzymes, liquid vitamins, toxin binders
- IFB Industries Limited · B2B laundry/dishwasher detergent formulations
- Millennium Papers · Pulp & paper specialty chemicals
- Panasonic India Pvt Ltd · Laundry/dishwasher detergent formulations
- RSPL / Rohit Surfactants (Ghadi) · Detergent ingredients/formulations
- Raymond Lifestyle Limited · Textile specialty chemicals
- Rentokil Initial Hygiene India · Institutional cleaning, hygiene & disinfection solutions
- Zoetis · Animal health & nutrition products
Buys from
- Gem Aromatics Limited · specialty ingredients (essential oils, aroma chemicals and derivatives)
- Hitech Corporation Limited · rigid plastic chemical and specialty-chemical packaging (carried forward from the prior pa…
- Vital Chemtech Limited · Phosphorus chemicals (P2O5, PPA) for textile auxiliaries
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Chemicals
- Industry
- Specialty Chemicals
- Classification
- Chemicals › Specialty Chemicals
- ISIN
- INE02A801020
Plants
- Rossari Dahej Plant · Dahej, Gujarat
- Rossari Silvassa Plant · Silvassa, Dadra and Nagar Haveli and Daman and Diu
- Rossari Thailand Plant
- Tristar Sarigam Plant · Sarigam, Gujarat
- Unitop Dahej Plant · Dahej, Gujarat
News impact
Big market events that reach Rossari Biotech Limited, and how the effect spreads.
No recent market events reach this company.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 10 Jul 2026 | unspecified | ₹0.5 |
|---|---|---|
| 20 Jun 2025 | unspecified | ₹0.5 |
| 16 Aug 2024 | unspecified | ₹0.5 |
| 24 May 2023 | unspecified | ₹0.5 |
| 7 Jul 2022 | unspecified | ₹0.5 |
| 8 Sep 2021 | unspecified | ₹0.5 |
Splits, bonuses & buybacks
- daily-prices repair: 7 rows from NSE's archive (replace 1, delete 1, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023
Bulk & block deals
| Date | Who | Bought / sold | Shares | Price |
|---|---|---|---|---|
| 30 Apr 2026 | BHUPESH KUMAR LODHA | BUY | 2,98,000 | ₹491.50 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Earnings call · Q1FY2720 Jul 2026
- Results presentation30 Jun 2026
- Annual report · 2025-2627 Jun 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.